IF YOUR
FROWN LINES
COULD
TALK

They’d say
“Try DAXXIFY® & get $50* off!”

*$50 rebate will be awarded as a prepaid e-gift card. Claims must be received by 4/6/26. See Terms & Conditions for details.

Woman with gentle smile
0 %
prefer DAXXIFY® over their previous frown line treatments.*
And you could too. It's a frown line treatment that acts fast, lasts long, and gives a radiant look. What's not to love?
*Based on a survey of 149 patients at week 2.

In clinical trial diaries, patients reported seeing a measurable improvement within 2 days of treatment. 74% achieved a ≥ 2-grade improvement at week 4 per both physician’s and patient’s assessment. More than 50% had no or minor frown lines until 6 months after treatment per both physician’s and patient’s assessments. In an open label study (N=27), 89% of patients agreed their skin looked radiant/bright (exploratory endpoint).

THREE BENEFITS,
ONE PEPTIDE FORMULATION.

DAXXIFY vial with peptide-powered formulation
DAXXIFY® is the first innovation in frown line treatments in 20 years. It’s the only one with a peptide formulation, and free of human and animal-based ingredients.
1.

Fast-acting

DAXXIFY® kicks in quickly. Most users see results as early as the next day and typically within two days after treatment.1

1Measurable improvement reported in clinical trial patient diaries.

2.

Long-lasting

DAXXIFY® is long-lasting and keeps frown lines smoother with results that slowly soften over a prolonged period.2

274% of patients in clinical studies had improvement at week 4 per both physician's and patient's assessments.

More than 50% had no or minor frown lines until 6 months after treatment per both physician's and patient's assessments.

3.

Radiant-looking results

Improves the appearance of skin texture after treatment, smoothing even the deepest lines.3, 4

3Improves the appearance of skin texture versus before treatment. In an open label study (N=27), 89% of patients agreed their skin looked radiant/bright (exploratory endpoint).

4In the same study (N=27), 96% of patients strongly agreed or agreed their skin looked smooth (exploratory endpoint)

See it in action.

Our formulation uses a peptide that forms a strong, magnet-like bond with the nerve cells, helping to deliver the active ingredient efficiently and make more of it available to work over time. Watch the video to learn more.

Thank you for your interest in DAXXIFY®

Now it's time to find a DAXXIFY® provider near you and redeem $50 off your first treatment. Please check your inbox for your unique rebate code and redemption instructions.

Locate a provider

Can’t find the email? Check your spam or junk folder for an email from DAXXIFY® with your code.

Mariana's Results

AT MAXIMUM FROWN
Results may vary.

BEFORE

AFTER

In clinical trial diaries, patients reported seeing a measurable improvement within 2 days of treatment. 74% achieved a ≥ 2-grade improvement at week 4 per both physician’s and patient’s assessment. More than 50% had no or minor frown lines until 6 months after treatment per both physician’s and patient’s assessments.

Find DAXXIFY® near you.

Ready to try the only peptide-formulated frown line treatment? Find a licensed provider and book today.

IMPORTANT SAFETY INFORMATION for DAXXIFY® (daxibotulinumtoxinA-Ianm) for injection
DAXXIFY® may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of DAXXIFY®: • Problems swallowing, speaking, or breathing due to weakening of associated muscles can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection.

IMPORTANT SAFETY INFORMATION for DAXXIFY® (daxibotulinumtoxinA-Ianm) for injection

DAXXIFY® may cause serious side effects that can be life threatening. Get medical help right away if you have any of these problems any time (hours to weeks) after injection of DAXXIFY®:

Problems swallowing, speaking, or breathing due to weakening of associated muscles can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.

Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms that include loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, and trouble swallowing.

Do not receive DAXXIFY® if you are allergic to any of the ingredients in DAXXIFY® (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as rimabotulinumtoxinB (MYOBLOC®), onabotulinumtoxinA (BOTOX®/BOTOX® Cosmetic), abobotulinumtoxinA (DYSPORT®), incobotulinumtoxinA (XEOMIN®) or prabotulinumtoxinA-xvfs (JEUVEAU®), or have a skin infection at the planned injection site.

DAXXIFY® dosing units are not the same as, or comparable to, any other botulinum toxin product.

Tell your healthcare provider about all your medical conditions, including any side effects from botulinum toxin products, including dry eye; breathing, swallowing, bleeding, or heart problems; plans to have surgery; weakness of forehead muscles; drooping eyelids; have had surgery on your face; are pregnant or breastfeeding or plan to become pregnant or breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using DAXXIFY® with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your healthcare provider that you have received DAXXIFY® in the past.

Especially tell your healthcare provider if you have received any other botulinum toxin product in the last 4 months or any in the past, and exactly which product you received (such as BOTOX®, BOTOX® Cosmetic, MYOBLOC®, DYSPORT®, XEOMIN®, or JEUVEAU®). DAXXIFY® may cause serious side effects, including allergic reactions (such as itching, rash, redness, swelling, wheezing, trouble breathing, or dizziness or feeling faint), heart problems (such as irregular heartbeat and heart attack), and eye problems (including dry eye, reduced blinking, and corneal problems). Tell your healthcare provider or get medical help right away if you experience a serious side effect. No serious adverse events of distant spread of toxin effect associated with dermatologic use of DAXXIFY® have been reported in clinical studies at the dose of 40 Units for glabellar lines. The most common side effects of DAXXIFY® include headache, eyelid drooping, and loss of ability to move the muscles in your face.

These are not all the possible side effects of DAXXIFY®. For more information, see the full Prescribing Information including Boxed Warning, and refer to the Medication Guide or talk with your doctor. To report side effects associated with DAXXIFY®, please call 1-877-373-8669. You may also report side effects to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

APPROVED USE
DAXXIFY® is a prescription medicine that is injected into muscles and used in adults to temporarily improve the look of moderate to severe frown lines between the eyebrows.

DAXI-001723.2